State of the Industry: Global Trends and Future Opportunities for Cell and Gene Therapies

State of the Industry: Global Trends and Future Opportunities for Cell and Gene Therapies

BioProduction Content - 3C49
BioProduction
Novel Modality Manufacturing Challenges & Solutions

Registered attendees

Albert Font
Albert Font
CEOLeanbio
AS
Alina Smotrova
Global Head of Corporate DevelopmentSHL Medical
Almira Bartolome
Almira Bartolome
Executive Director, Commercial Development, Advanced Therapies and VaccinesFUJIFILM Diosynth Biotechnologies

Log in

See all the content and easy-to-use features by logging in or registering!